US Stock MarketDetailed Quotes

CNSP CNS Pharmaceuticals

Watchlist

0.2195
+0.0199+9.97%

Trading May 16 14:59 ET

2.60MMarket Cap-77P/E (TTM)

CNS Pharmaceuticals Stock Forum

Trytosaveabit

6 hours ago

$CNS Pharmaceuticals(CNSP.US)$ CNS Pharmaceuticals (NASDAQ:CNSP) reported quarterly losses of $(0.41) per share. This is a 84.17 percent increase over losses of $(2.59) per share from the same period last year.

Trytosaveabit

May 9 04:10

Update

$CNS Pharmaceuticals(CNSP.US)$ On May 6, 2024, the Company received notification from the Nasdaq Hearings Panel (“Panel”) that it has granted an extension until July 15, 2024, to demonstrate compliance with Listing Rules 5550(a)(2) and 5550(b). The Company intends to implement its plan to meet the milestones set forth by the Panel prior to July 15, 2024.

wooper

Mar 6 01:06

excellent sold Open hymer time

Share Your Profit/Loss

wooper

Mar 5 21:37

Share Your Profit/Loss

wooper

Mar 5 02:24

Share Your Profit/Loss

DigitalGaines

Mar 5 01:44

$CNS Pharmaceuticals(CNSP.US)$ On Radar

Trytosaveabit

Feb 28 07:14

Just throwing this out there! May want to watch?

$CNS Pharmaceuticals(CNSP.US)$ This thing is oversold! Its just recently off ATL/52wk! Also they got a extension on minimum bid of 1.00 compliance until August 14, 2024! They have also filed for a hearing on the 2.5 Million shareholder value! Which i believe they should be in compliance with when the 4 Million offering closes! They have brought in a new board to right the ship! And we have a newer 13G/A by Armistice Capital who now has 673,203 shar...

Trytosaveabit

Jan 17 21:55

Update

$CNS Pharmaceuticals(CNSP.US)$ CNS Pharmaceuticals Achieves Completion of Planned Enrollment in Potentially Pivotal Study of Berubicin for the Treatment of Glioblastoma Multiforme (GBM)

Trytosaveabit

Dec 19, 2023 04:45

With this news! This drop make zero sense

$CNS Pharmaceuticals(CNSP.US)$ CNS Pharmaceuticals Announces Successful Interim Analysis of Efficacy and Safety Data in Potentially Pivotal Study of Berubicin
Independent DSMB recommends continuing clinical trial of Berubicin without modification

wooper

Oct 21, 2023 01:02

looks good

$CNS Pharmaceuticals(CNSP.US)$

CNS Pharmaceuticals(CNSP) 2.1199 +7.61%

No comment yet

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall